Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
06/2005
06/15/2005CN1626530A Spiro and dispiro -1,2,4-trioxalane antimalarials
06/15/2005CN1626527A Pyran derivative, method for manufacturing the same, and light-emitting element containing the pyran derivative
06/15/2005CN1206228C N-heterocyclic derivatives as NOS inhibitors
06/15/2005CN1206219C N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/14/2005US6906632 Vehicular sound-processing system incorporating an interior mirror user-interaction site for a restricted-range wireless communication system
06/14/2005US6906205 Spiro and dispiro 1,2,4-trioxolane antimalarials
06/14/2005US6906188 Method for synthesizing epothilones and epothilone analogs
06/14/2005US6906104 Aminediols for the treatment of Alzheimer's disease
06/14/2005US6906095 Central nervous system disorders; anxiolytic agents; antidepressants; muscular disorders
06/14/2005US6906093 Indolinone combinatorial libraries and related products and methods for the treatment of disease
06/14/2005US6906089 Kidney disease; cardiovascular disorders; antiscarring agents; wound healing agents
06/14/2005US6906084 Indole derivatives as factor Xa inhibitors
06/14/2005US6906075 Contacting a sample with substituted benzoimidazole analogues under conditions that permit binding of such analogue to melanin concentrating hormone (MCH) receptor to determine the presence and absence of MCH
06/14/2005US6906072 Central nervous system disorders
06/14/2005US6906066 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/14/2005US6906063 For therapy and prophylaxis of thrombosis in a mammal
06/14/2005US6906058 Prevent bile acid transportation; anticholesterol agents
06/14/2005US6906053 Antiarthritic agents; antiulcer agents; osteoporosis; antiinflammatory agents; antitumor and anticancer agents
06/14/2005US6905786 A thin layer contains aromatic tert-amine compound, sandwiched between a pair of electrodes; brightness
06/14/2005CA2333703C Isothiazole derivatives useful as anticancer agents
06/14/2005CA2304967C 4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
06/14/2005CA2234096C 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives
06/09/2005WO2005051947A1 Thiaepothilone for treating cancerous diseases
06/09/2005WO2005051946A2 Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
06/09/2005WO2005051945A1 Heterocyclic compounds as modulators of peroxisome proliferator activated receptors, useful for the treatment and/or prevention of disorders modulated by a ppar
06/09/2005WO2005051932A1 Arylheterocycle derivative and agricultural or horticulrual bactericide and insecticide
06/09/2005WO2005051931A2 Phosphodiesterase inhibitors
06/09/2005WO2005051923A1 Quinazoline derivatives
06/09/2005WO2005051913A1 Cyclic amine derivative having heteroaryl ring
06/09/2005WO2005051906A2 Heterocyclic inhibitors of mek and methods of use thereof
06/09/2005WO2005051391A1 Quinazolinone compounds with reduced bioaccumulation
06/09/2005WO2005051387A1 Amino substituted pyridinyl methanone compounds useful in treating kinase disorders
06/09/2005WO2005051381A1 Substituted urea-octatydroindols as antagonists of melanin concentrating hormone receptor 1 (MCH1R)
06/09/2005WO2005051302A2 Bicyclic inhibitors of mek and methods of use thereof
06/09/2005WO2005051301A2 Heterocyclic inhibitors of mek and methods of use thereof
06/09/2005WO2005051300A2 Bicyclic inhibitors of mek and methods of use thereof
06/09/2005WO2005051110A1 Corrective clothes with crotch
06/09/2005WO2005035508A3 Method for producing acyl urea derivatives, salts of said acyl urea derivatives, and the use thereof as pesticides
06/09/2005WO2005016893A3 2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases
06/09/2005WO2004068946A3 Thiabendazole sorbate, method for the production thereof, and use thereof
06/09/2005US20050124672 Antineoplastic agents, analgesics, antipyretics; prostaglandin E2 receptor antagonists; 3-Methyl-4-[6-[N-isobutyl-N-(2-thiazolylsulfonyl)amino]indan-5-yloxymethyl]benzoic acid, a C1-4 alkyl ester, or a non-toxic salt
06/09/2005US20050124671 Benzylcycloalkyl amines as modulators of chemokine receptor activity
06/09/2005US20050124670 Novel arylazole derivatives, their manufacture and use as pharmaceutical agents
06/09/2005US20050124664 Compounds for treatment of cardiovascular disorders using inhibitors of plasmnogen activator as anticoagulants for blood
06/09/2005US20050124661 Inhibitors of peroxisome proliferation, enzyme inhibitors to treat obesity and other diseases
06/09/2005US20050124654 Compounds and methods of use
06/09/2005US20050124641 Process for preparing chiral diol sulfones and dihydroxy acid HMG CoA reductase inhibitors
06/09/2005US20050124631 For example, 2-amino-7-chloro-6-hydroxy-4-methylbenzothiazole; compounds that prevent the formation of polyglutamine containing protein aggregates; treatment of spinal and bulbar muscular atrophy, dentatorubal pallidoluysian atrophy, spinocerebellar ataxia, Alzheimers disease
06/09/2005US20050124625 For example, ((2R,5S)-4-(8-cyano-quinolin-5-yl)-2,5-dimethyl-piperazine-1-carboxylic acid(4-trifluoromethyl-pyridin-3-yl)-amide); use in treatment of nuclear hormone receptor-associated conditions such as cancer and immune disorders
06/09/2005US20050124619 Medical devices employing triazine compounds and compositions thereof
06/09/2005US20050124617 Agonists to a cannabinoid type 2 receptor; antiinflammatory agents; immunosuppressants; nephritis
06/09/2005US20050124614 E. g., 3,5-bis-trifluoromethylphenyl)-4-[(furan-2-ylmethyl)-aminocarbonyl]-2-methyl-1-oxo-1,2,3,4-tetrahydroisoquinoline;anticarcinogenic agents; antitumor agents; antiproliferative agents; activators of the caspase cascades; enzyme inhibitors used in combination with radiation or chemotherapy
06/09/2005US20050124611 Such as N-[4-[[4-(5-chloro-2-hydroxyphenyl)-1,2-dihydro-2-oxo-6-(trifluoromethyl)-3-quinolinyl]thio]phenyl]-4-morpholineacetamide; potassium channel modulators
06/09/2005US20050124610 cyclin dependent kinase (CDK) inhibitors useful in treating or ameliorating a CDK mediated disorder consisting of cervical adenocarcinoma, colon carcinoma and malignant melanoma
06/09/2005US20050124607 5-Substituted quinazolinone compounds useful as alpha 1A/B adrenergic receptor antagonists
06/09/2005US20050124606 Novel benzothiazine and benzothiadiazine derivatives method for preparing same and pharmaceutical compositions containing same
06/09/2005US20050124603 Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands
06/09/2005US20050124602 1-(3-chlorophenyl)-7-oxo-6-[4-(2-oxo-1(2H)pyridinyl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide; treating a thromboembolic disorder such as deep vein thrombosis or pulmonary embolism
06/09/2005US20050124577 8-Azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
06/09/2005US20050124562 Using Dna polymerase inhibitor as bactericide
06/09/2005US20050124497 Pesticide, 5-tert-butyl-2-{4-[5-(2,6-difluorophenyl)-3,4-dihydro-2H-pyrrol-2-yl]phenyl}-1,3-benzoxazole; chemical intermediates, N-(5-tert-butyl-2-hydroxyphenyl)-4-[5-(2,6-difluorophenyl)-3,4-dihydro-2H-pyrrol-2-yl]benzamide; applying on plants, animals
06/09/2005US20050124209 Illuminated electrical cords and outlets
06/09/2005US20050123831 used for ionic conducting materials, electronic conducting materials, colorant, and the catalysis of various chemical reactions
06/09/2005US20050123533 Prodrugs activated by targeted catalytic proteins
06/09/2005CA2547472A1 Cyclic amine derivative having heteroaryl ring
06/09/2005CA2546709A1 Amino substituted pyridinyl methanone compounds useful in treating kinase disorders
06/09/2005CA2546486A1 Heterocyclic inhibitors of mek and methods of use thereof
06/09/2005CA2546353A1 Bicyclic inhibitors of mek and methods of use thereof
06/09/2005CA2545660A1 Heterocyclic inhibitors of mek and methods of use thereof
06/09/2005CA2545659A1 Bicyclic inhibitors of mek
06/09/2005CA2545601A1 Quinazolinone compounds with reduced bioaccumulation
06/09/2005CA2545262A1 Quinazoline derivatives
06/09/2005CA2543858A1 Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
06/08/2005EP1537870A2 Methods and compositions for treating cancer
06/08/2005EP1537180A1 Process for preparing azo compound
06/08/2005EP1537123A1 Compounds
06/08/2005EP1537111A1 Hetereoaryl nitrile derivatives
06/08/2005EP1537091A1 Novel 2-arylthiazole compounds as pparalpha and ppargamma agonists
06/08/2005EP1537084A1 Substituted 2-alkylamine nicotinic amide derivatives and use there of
06/08/2005EP1537081A1 Dihydropyridine derivatives for use as human neutrophil elastase inhibitors
06/08/2005EP1536797A1 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related comounds as neurokinin-1 (nk-1) antagonsists for the treatment of emesis, depression, anxiety and cough
06/08/2005EP1536784A1 Hetero biaryl derivatives as matrix metalloproteinase inhibitors
06/08/2005EP1337526B1 Substituted imidazoles useful in the treatment of inflammatory diseases
06/08/2005EP1309575B1 Biphenyl derivatives and their use as ppar-gamma receptor activators
06/08/2005EP1189895B1 Thiazole and oxazole derivatives and their pharmaceutical use
06/08/2005EP1089735B1 4-benzyl piperidine alkylsulfoxide heterocycles and their use as subtype-selective nmda receptor antagonists
06/08/2005CN1625410A 2, 4, 6-triamino-1, 3, 5-triazine derivative
06/08/2005CN1625400A 2, 4-pyrimidinediamine compounds and their uses
06/08/2005CN1623992A Novel medicine of non peptide like angiotensin II receptor antagonism agent, their preparation and application
06/08/2005CN1623991A Substituded acza nember 5/nember 6 ring compound and its preparation process
06/08/2005CN1623984A Fused-ring compounds and use thereof as drugs
06/08/2005CN1623537A Biaryl sulfonamides and its using method
06/08/2005CN1205213C Method for the production of imidazol-[1,2-c][2,3]-benzodiazepines and intermediates in production thereof
06/08/2005CN1205208C C-21 modified epothilones
06/08/2005CN1205207C Substituted indolealkanoic acids
06/08/2005CN1205202C N-carbanilides used as pesticides
06/08/2005CN1205194C Biphenyl ether oxazolines and their use as pest-control agents
06/08/2005CN1205185C Nitrogenous cyclic compounds and pharmaceutical compositions containing the same
06/08/2005CN1205183C New amidino derivatives and their use as thrombin inhibitors
06/07/2005US6903217 Heterocyclylalkylpiperidine derivatives, their preparation and compositions containing them
1 ... 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 ... 628